Technological advances, more chronic disease, and a larger worldwide geriatric population will power growth in the world medical imaging market through 2022, according to a new report from Allied Market Research.
The report projects a compound annual growth rate (CAGR) of 5% from 2015 to 2022, which would increase the global market's value to $45 billion. North America and the Asia-Pacific region each accounted for approximately one-third of the global medical imaging market in 2015.
Other highlights include the following:
- The x-ray imaging systems segment generated the most revenue in 2015, accounting for more than 25% of the overall market revenue, and is projected to grow at a CAGR of 3.7% during the forecast period.
- The mammography systems segment is expected to grow at a CAGR of 8.3% due to innovation and digitization of mammography devices.
- China and Japan are the biggest markets in the Asia-Pacific region, jointly accounting for more than 50% of the Asia-Pacific medical imaging market.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
